VIETNAM DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)

VIETNAM DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)

The Vietnam Diabetes Care Devices Market is expected to register a CAGR greater than 2% over the forecast period, 2022-2027.

Among the nations affected by the COVID-19 epidemic, Vietnam has effectively stopped transmission since the beginning, with no deaths for months. However, the fourth wave of the COVID-19 epidemic has been wreaking havoc on Vietnam since then. Vietnam has seen four waves of the COVID-19 pandemic, according to the Ministry of Health (MOH).

The coronavirus disease-2019 (COVID-19) has been identified as a highly contagious viral illness caused by the coronavirus-2 that causes severe acute respiratory syndrome (SARS-CoV-2). Diabetes is one of the biggest risk factors for deadly COVID-19 outcomes. Diabetes patients are at risk of infection due to hyperglycemia, decreased immune function, vascular problems, and comorbidities such as hypertension, dyslipidemia, and cardiovascular disease. Furthermore, in the human body, angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV-2. As a result, the use of angiotensin-converting enzyme (ACE) inhibitors in diabetic patients requires special consideration. COVID-19 severity and mortality were considerably greater in diabetic individuals than in those without. As a result, diabetic individuals should take care during the COVID-19 pandemic.

In Vietnam, according to the Ministry of Health, 29,000 patients die due to diabetes, annually. In order to prevent this situation, the ministry initiated a training program to improve the diagnosis of diabetes and the treatment capacity of medical professional’s in taking care of diabetic patients in Vietnam during 2019-2020.

Key Market TrendsManagement Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market

Health insurance was introduced in Vietnam greater than 10 years ago, but the coverage is still relatively low. Vietnam is a low- to a middle-income country, with a per-capita GDP of around USD 4310. As a result, the expense of diabetes treatment places a significant strain on a patient's family budget. Diabetes medicine is inexpensive in HCMC as compared to the expense of treating other chronic disorders, including infectious, cardiovascular, and renal problems. The lack of government policies and healthcare schemes is impacting the growth of the market for management devices in Vietnam. The country’s population of those over the age of 60 years has created pressures on the healthcare system, as well as social security services and policies. Thus, the government needs to establish new policy programs that can reduce the burden of healthcare costs for diabetes treatment.

Digital companies are trying to improve the conditions of diabetic patients by reminding them when to test their glucose levels and passing the information to doctors and family members. According to a study conducted by GlucoMe (digital diabetes platform), along with Merck at several endocrinology clinics and hospitals in Vietnam, the use of GlucoMe applications reduced the risks of the major issues related to diabetes for Type 2 diabetic patients. The awareness among diabetic patients in Vietnam is expected to increase the growth of the market for management devices in the country during the forecast period.

Increasing Diabetes Population in Vietnam

Diabetes is one of the four major non-communicable diseases (NCDs) and its global prevalence has been steadily increasing in recent years. In Vietnam, Diabetes is rising at a rate of about 6.23% every year, and it has become a serious health and economic burden for Vietnamese society. Economic growth and changes in the social environment have an impact on disease patterns ranging from infectious illnesses to noncommunicable diseases, with diabetes being one of the seven top causes of death and disability in Vietnam. The prevalence of obesity in Vietnam is still relatively low, although it has increased substantially during the past decade, particularly over the past 5 years. There has been a major shift in dietary habits that parallel the changes observed in obesity prevalence rates. Cigarette smoking is a major risk factor for diabetes in Vietnam. A recent meta-analysis suggests that cigarette smokers are 44%more likely to have diabetes than non-smokers. Although there is a high prevalence of cigarette smoking in Vietnamese men, this trend is decreasing.

Diabetes is recognized as a public health burden in Vietnam and public health authorities have taken measures to reduce the burden. The diabetes burden in Vietnam results from several epidemiologic changes and drivers. Diabetes has the potential to reach epidemic proportions and as a result, confer tremendous public health and economic burden in Vietnam. Although the prevalence of diabetes in rural areas is still relatively low, it is on the rise. In major cities, the prevalence of diabetes is as high as in any other Western population. The increase in the diabetes prevalence rates correlates with changes in risk factors, such as adiposity and a Westernized dietary pattern. It is generally believed that diabetes is preventable through lifestyle changes that include healthy eating and consistent physical activity, but more research is needed to validate this premise for the Vietnamese community.

Competitive Landscape

The new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Industry Attractiveness - Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Monitoring Devices
5.1.1 Self-monitoring Blood Glucose Devices (Value and Volume, 2016 - 2027)
5.1.1.1 Glucometer Devices
5.1.1.2 Test Strips
5.1.1.3 Lancets
5.1.2 Continuous Blood Glucose Monitoring (Value and Volume, 2016 - 2027)
5.1.2.1 Sensors
5.1.2.2 Durables
5.2 Management Devices
5.2.1 Insulin Pump (Value and Volume, 2016 - 2027)
5.2.1.1 Insulin Pump Device
5.2.1.2 Insulin Pump Reservoir
5.2.1.3 Infusion Set
5.2.2 Insulin Syringes (Value and Volume, 2016 - 2027)
5.2.3 Insulin Cartridges (Value and Volume, 2016 - 2027)
5.2.4 Disposable Pens (Value and Volume, 2016 - 2027)
6 MARKET INDICATORS
6.1 Type-1 Diabetes population (2016-2027)
6.2 Type-2 Diabetes population (2016-2027)
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Becton and Dickenson
7.1.2 Medtronic
7.1.3 Insulet
7.1.4 Tandem
7.1.5 Ypsomed
7.1.6 Novo Nordisk
7.1.7 Sanofi
7.1.8 Eli Lilly
7.1.9 Abbottt
7.1.10 Roche
7.1.11 Lifescan (Johnson &Johnson)
7.1.12 Dexcom
7.2 Company Share Analysis
8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings